Lungcancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Lungcancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06036563

Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing

The goal of this observational study is to screen and differentiate common cancers in participants with or without suspicious lesions. The main question the inv…

China3,200 participantsStarted 2023-09-01

All recent trials (11 shown)

TerminatedPhase 1

NCT03114319

Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

The purpose of this first in human (FIH) trial was to characterize the safety and tolerability of the SHP2 inhibitor TNO155 alone and in combination with EGF816…

United States, Canada227 participantsStarted 2017-05-26

Treatment: TNO155, TNO155 in combination with EGF816 (nazartinib)

Not Yet RecruitingNot Applicable

NCT07506889

Simplified Exercise-based Risk Assessment in Lung Cancer

Physiological evaluation is part of the preoperative risk estimation in patients with lung cancer, and it aids in the choice of treatment. Ventilatory efficienc…

Sweden500 participantsStarted 2026-04-01

Lungcancer

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing

All recent trials (11 shown)

Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

Simplified Exercise-based Risk Assessment in Lung Cancer

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing

All recent trials (11 shown)

Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors

Simplified Exercise-based Risk Assessment in Lung Cancer

Effects of Preoperative Rehabilitation in Patients Resected for Lung Cancer

A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squam…

Prospective Primary Human Lungcancer Organoids to Predict Treatment Response

Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKI

Imaging Multiparametric/Multimodality for Lungcancer

SHOX2_PTGER4 DNA Methlyation in Lung Cancer

Effect Of Ketamine Infusion In Patients With COPD Applied One Lung Ventilation

HD+ I-scan Bronchoscopy Vascular Abnormalities Detection Multicenter Study